This announcement is a separate document:
藥明生物：分拆WUXI XDC CAYMAN INC. 並於香港聯合交易所有限公司主板獨立上市的最新資料 - 超額配股權獲悉數行使
WUXI BIO: UPDATE ON THE SPIN-OFF AND SEPARATE LISTING OF WUXI XDC CAYMAN INC. ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED - FULL EXERCISE OF THE OVER-ALLOTMENT OPTION
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.